Recombinant BNP on Heart and Renal Function in Acute Heart Failure
Status:
Unknown status
Trial end date:
2013-12-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to evaluate the efficacy and safety of recombinant human B-type
natriuretic peptide (rhBNP) on heart and renal function in patients with acute decompensated
heart failure (ADHF) and acute renal injury (AKI).